ofa lawsuit semaglutide FDA sued over 'reckless and arbitrary' decision Ozempic Class Action Lawsuit Explained:

Clinical data shows that GLP-1 RAs can reduce the risk of major adverse cardiovascular events (MACE) in diabetic patients

This may be attributed to rapid improvement in glucose control, but more research is needed

Existing evidence doesnt suggest tirzepatide poses a risk of birth defects after early inadvertent exposure, but thats a different statement from saying its safe to use during pregnancy

Indian distribution network keeps transit time short and customs friction near zero compared to imports

The mean changes from baseline in HbA1c were 2.4% at week 16 in the tirzepatide 2.510.0 mg group and 1.6% at week 24 in the tirzepatide 2.515.0 mg group (Supplementary Table S2)

Frequently Asked Questions worth asking before you begin